Reduced-Intensity Conditioning Allogeneic Blood Stem Cell Transplantation with Fludarabine and Oral Busulfan with or without Pharmacokinetically Targeted Busulfan Dosing in Patients with Myeloid Leukemia Ineligible for Conventional Conditioning-Reference-Cited by-同舟云学术

Reduced-Intensity Conditioning Allogeneic Blood Stem Cell Transplantation with Fludarabine and Oral Busulfan with or without Pharmacokinetically Targeted Busulfan Dosing in Patients with Myeloid Leukemia Ineligible for Conventional Conditioning

Published:2005-06 Issue:6 Volume:11 Page:437-447
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Martino Rodrigo,Pérez-Simón José A.,Moreno Estela,Queraltó José M.,Caballero Dolores,Mateos Marivi,Sureda Anna,Cañizo Consuelo,Brunet Salut,Briones Javier,Vazquez Lourdes,Clopés Ana,San Miguel Jesús F.,Sierra Jorge

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference62 articles.

1. Allogeneic hemopoietic stem cell transplantation in patients with myelodysplastic syndrome or myelofibrosis;Deeg;Int J Hematol,2002

2. Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age;Deeg;Blood,2000

3. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia;Sierra;Blood,2002

4. Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias;de Witte;Br J Haematol,2000

5. Busulfan-cyclophosphamide versus total body irradiation-cyclophosphamide as preparative regimen before allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia;Ferry;Exp Hematol,2003

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Severity and organ distribution of graft‐versus‐host disease with post‐transplant cyclophosphamide versus calcineurin inhibitor plus methotrexate/mycophenolate mofetil or sirolimus in allogenic HLA‐matched or single‐allele mismatched stem cell transplantation;European Journal of Haematology;2024-08-18

2. Feasibility of thiotepa addition to the fludarabine-busulfan conditioning with tacrolimus/sirolimus as graft vs host disease prophylaxis;Leukemia & Lymphoma;2020-07-02

3. Decision Analysis of Transplantation for Patients with Myelodysplasia: “Who Should We Transplant Today?”;Current Hematologic Malignancy Reports;2020-03-28

4. Incorporating posttransplant cyclophosphamide-based prophylaxis as standard-of-care outside the haploidentical setting: challenges and review of the literature;Bone Marrow Transplantation;2019-12-10

5. Cardiac Complications in the Adult Bone Marrow Transplant Patient;Current Oncology Reports;2019-03